Primary entity: SR9009Also known as: Stenabolic; SR-9009Class: performance-adjacent literacy (see page)Cluster: Performance-adjacent
SR9009 (Stenabolic) is a synthetic agonist of REV-ERB nuclear receptors studied mainly in cells and mice for circadian/metabolic and exercise-capacity phenotypes — it is not a SARM and not a peptide. It is not FDA-approved, lacks meaningful registered human efficacy trials as an approved medicine, and is prohibited by WADA as a Rev-erb agonist under Hormone and Metabolic Modulators (examples include SR9009, SR9011).
SR9009 is not a peptide and not a SARM. USADA notes it is sometimes marketed as a SARM. Correct class: REV-ERB agonist (metabolic modulator), same broad anti-doping neighborhood as Cardarine (PPARδ) — different receptor.
Never approved as a medicine. Evidence base is overwhelmingly preclinical. WADA: Rev-erbɑ agonists e.g. SR9009, SR9011 listed under metabolic modulators — prohibited at all times. Sanctions involving SR9009 metabolites have been reported in anti-doping news — enforcement is real.
Key takeaways
- Not a peptide and not a SARM — REV-ERB agonist.
- Not FDA-approved; human clinical development as a consumer drug is not established.
- WADA-prohibited metabolic modulator
- “Exercise in a bottle” is forum branding from mouse exercise-capacity narratives.
- No dosage charts here.
Questions this page answers
Next questions we answer on this page (curiosity / AI-gap map):
- What is SR9009?
- Aliases
- Classification
- What it is NOT
- Mechanism (REV-ERB)
- Evidence ladder
- What has been studied
- Safety literacy
- Regulatory & WADA
- Why no dosages
- Related
- Who for / not for
Who is this profile for — and who is it not for?
For: readers who saw Stenabolic next to RAD-140 in a shop and need class correction.
Not for: endurance-cycle seekers.
What is SR9009?
SR9009 is a REV-ERBα/β agonist from the Burris/Scripps research lineage. Mouse work linking REV-ERB activation to mitochondrial and exercise-capacity phenotypes drove the “exercise mimetic” folk reputation. Related tool compound: SR9011.
| Chemistry class | REV-ERB agonist |
|---|---|
| Peptide? | No |
| SARM? | No |
| Folk name | Stenabolic |
| Sport | WADA Rev-erb agonists |
Also known as
- SR9009 / SR-9009 — research code.
- Stenabolic
Online nickname— vendor/folk name. - SR9011 — related REV-ERB agonist (sibling literacy).
- Mis-tags: “Stenabolic SARM,” “SR9009 peptide.”
False by chemistry and by WADA section. SARMs → S1.2 anabolic agents. SR9009 → metabolic modulators (Rev-erb agonists).
How is SR9009 classified?
Investigational / research metabolic modulator — REV-ERB agonist small molecule. Performance-adjacent cluster with cardarine-like SERP demand.
What is SR9009 not?
| SR9009 is not… | Why that matters |
|---|---|
| A peptide | Small molecule |
| A SARM | Different receptor class |
| FDA-approved exercise drug | No approval; preclinical-heavy evidence |
| Cardarine | Cardarine is PPARδ; SR9009 is REV-ERB |
| Something we dose | Refusal |
How is SR9009 thought to work?
REV-ERB receptors participate in circadian and metabolic gene programs. Agonism in models alters mitochondrial and metabolic phenotypes. Some effects may involve REV-ERB-independent mechanisms in published caveats — treat mechanism as research literacy.
What human vs animal vs label evidence exists?
| Evidence type | What exists (summary) | Maturity |
|---|---|---|
| Human RCTs as approved drug | Not established / no approval pathway completed | None |
| Animal | Mouse metabolic / exercise-capacity models | Animal |
| Cell / in vitro metabolism | Metabolic profiling for anti-doping detection | Cell |
| Forum endurance claims | Anecdote | None |
This page does not convert mouse endurance results into unsourced human percentages.
What has SR9009 been studied for?
Circadian biology, metabolism, and exercise-capacity phenotypes in animals; anti-doping metabolism/detection papers. Studied ≠ approved.
What safety topics come up?
No approved PI. Human safety as a performance agent is unestablished. Unregulated products add purity risk. Case-report noise in secondary sources should be verified before evergreen citation. Not medical advice.
What is SR9009's regulatory status?
- U.S.: Not FDA-approved.
- WADA: Rev-erb agonists e.g. SR9009, SR9011
- Sport: Metabolic-modulator positives/sanctions have occurred — check GlobalDRO.
Why doesn't this page include a dosage chart?
“SR9009 dosage / Stenabolic cycle” refused.
Related lab literacy
Not peptide reconstitution. What are peptides?.
Related compounds and comparisons
- Cardarine — PPARδ agonist (also not a SARM).
- SLU-PP-915 — ERR agonist research tool.
- RAD-140 — true SARM often co-marketed incorrectly.
Frequently asked questions
Is SR9009 a peptide?
No.
Is SR9009 a SARM?
No. It is a REV-ERB agonist; WADA files it with metabolic modulators.
Is Stenabolic the same as SR9009?
Stenabolic is the common folk/vendor name.
Is it WADA banned?
Yes as a Rev-erb agonist example.
Has it been proven in humans?
No approved human medicine; evidence is preclinical-heavy.
Not a peptide, not a SARM, WADA-relevant, not medical advice. Disclaimer..
Sources
The sources below were checked against PubMed, DailyMed, or the official agency page on November 10, 2026 (America/Phoenix). Links go to the publisher, PubMed, or the agency record.
- Primary — animal Solt LA, Wang Y, Banerjee S, et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature. 2012. doi:10.1038/nature11030. PMID: 22460951. Preclinical (non-human) study.
- Safety — human case Shams Bin Shaheen S, Liu WJP, Cooper C, Wu MY. Acute Liver Failure in an Adolescent Following Use of the Synthetic REV-ERB Agonist SR9009. Case Reports Hepatol. 2026. doi:10.1155/crhe/9926772. PMID: 42750938.
- Anti-doping World Anti-Doping Agency. The World Anti-Doping Code International Standard Prohibited List 2026. Accessed November 10, 2026. Confirm the current list and GlobalDRO before relying on sport status. The 2026 list names Rev-erbα agonists, e.g. SR9009 and SR9011, among metabolic modulators (S4.4).
- Written by
- Peptide Tutorials Staff — a group of independent researchers & writers (not clinicians)
- Published · Updated
- Oct 7, 2026 · Oct 7, 2026 · Regulatory and sport-status wording checked November 10, 2026 against current FDA labels and the 2026 WADA Prohibited List · How we source & update
Educational disclaimer: Educational only. SR9009 is not a peptide and not a SARM. No dosing or buy links. We don't sell peptides. Read our full disclaimers.